J. Goldman & Co’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,963
| Closed | -$3.73M | – | 388 |
|
|
2024
Q1 | $3.73M | Buy |
20,963
+15,555
| +288% | +$2.77M | 0.12% | 120 |
|
|
2023
Q4 | $671K | Sell |
5,408
-29,805
| -85% | -$3.7M | 0.03% | 163 |
|
|
2023
Q3 | $4.08M | Buy |
35,213
+29,864
| +558% | +$3.46M | 0.14% | 102 |
|
|
2023
Q2 | $628K | Buy |
5,349
+2,650
| +98% | +$311K | 0.02% | 179 |
|
|
2023
Q1 | $216K | Sell |
2,699
-16,620
| -86% | -$1.33M | 0.01% | 219 |
|
|
2022
Q4 | $1.53M | Buy |
19,319
+9,392
| +95% | +$744K | 0.08% | 148 |
|
|
2022
Q3 | $692K | Sell |
9,927
-4,063
| -29% | -$283K | 0.03% | 196 |
|
|
2022
Q2 | $919K | Sell |
13,990
-17,869
| -56% | -$1.17M | 0.04% | 177 |
|
|
2022
Q1 | $2.12M | Buy |
+31,859
| New | +$2.12M | 0.1% | 134 |
|
|
2021
Q4 | – | Sell |
-6,300
| Closed | -$329K | – | 297 |
|
|
2021
Q3 | $329K | Sell |
6,300
-4,651
| -42% | -$243K | 0.02% | 224 |
|
|
2021
Q2 | $745K | Buy |
10,951
+76
| +0.7% | +$5.17K | 0.03% | 242 |
|
|
2021
Q1 | $838K | Sell |
10,875
-5,543
| -34% | -$427K | 0.03% | 243 |
|
|
2020
Q4 | $985K | Sell |
16,418
-17,254
| -51% | -$1.04M | 0.05% | 191 |
|
|
2020
Q3 | $1.45M | Sell |
33,672
-11,530
| -26% | -$497K | 0.1% | 136 |
|
|
2020
Q2 | $1.87M | Buy |
+45,202
| New | +$1.87M | 0.12% | 128 |
|